MD2849F1 - Metoda de tratament al cancerului mamar la pacientele de varsta inaintata - Google Patents
Metoda de tratament al cancerului mamar la pacientele de varsta inaintata Download PDFInfo
- Publication number
- MD2849F1 MD2849F1 MDA20050133A MD20050133A MD2849F1 MD 2849 F1 MD2849 F1 MD 2849F1 MD A20050133 A MDA20050133 A MD A20050133A MD 20050133 A MD20050133 A MD 20050133A MD 2849 F1 MD2849 F1 MD 2849F1
- Authority
- MD
- Moldova
- Prior art keywords
- patients
- cancer treatment
- old age
- mammary cancer
- solution
- Prior art date
Links
- 206010006187 Breast cancer Diseases 0.000 title abstract 2
- 208000026310 Breast neoplasm Diseases 0.000 title abstract 2
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 abstract 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000002526 effect on cardiovascular system Effects 0.000 abstract 1
- 229960002949 fluorouracil Drugs 0.000 abstract 1
- 229960004194 lidocaine Drugs 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000000926 neurological effect Effects 0.000 abstract 1
- 230000007170 pathology Effects 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Inventia se refera la medicina, in special la oncologie si poate fi utilizata pentru tratamentul cancerului mamar la pacientele de varsta inaintata cu patologii concomitente severe cardiovasculare, neurologice etc. Esenta inventiei consta in aceea ca se infiltreaza local in regiunea tumorii un amestec de solutie de lidocaina de 0,2% in cantitate de 150...200 ml si solutie de 5-fluorouracil in cantitate de 750 mg/m2, apoi se efectueaza interventia chirurgicala si se sutureaza plaga pe straturi.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDA20050133A MD2849G2 (ro) | 2005-05-16 | 2005-05-16 | Metodă de tratament al cancerului mamar la pacientele de vârstă înaintată |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDA20050133A MD2849G2 (ro) | 2005-05-16 | 2005-05-16 | Metodă de tratament al cancerului mamar la pacientele de vârstă înaintată |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MD2849F1 true MD2849F1 (ro) | 2005-09-30 |
| MD2849G2 MD2849G2 (ro) | 2006-04-30 |
Family
ID=35057540
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MDA20050133A MD2849G2 (ro) | 2005-05-16 | 2005-05-16 | Metodă de tratament al cancerului mamar la pacientele de vârstă înaintată |
Country Status (1)
| Country | Link |
|---|---|
| MD (1) | MD2849G2 (ro) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MD3772G2 (ro) * | 2008-05-12 | 2009-07-31 | Общественное Медико-Санитарное Учреждение Онкологический Институт | Metodă de tratament al cancerului glandei mamare cu metastaze |
| MD36Z (ro) * | 2008-12-02 | 2010-01-31 | Василе ЖОВМИР | Metodă de tratament diferenţiat al carcinomului ductal in situ neinvaziv al glandei mamare |
| MD24Z (ro) * | 2008-12-02 | 2010-01-31 | Василе ЖОВМИР | Metodă de tratament diferenţiat al carcinomului neinvaziv al glandei mamare |
| MD23Z (ro) * | 2008-12-02 | 2010-01-31 | Василе ЖОВМИР | Metodă de tratament diferenţiat al carcinomului lobular in situ neinvaziv al glandei mamare |
| MD35Z (ro) * | 2008-12-02 | 2010-01-31 | Василе ЖОВМИР | Metodă de apreciere a riscului dezvoltării carcinomului neinvaziv in situ al glandei mamare |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MD106C2 (ro) * | 1993-11-12 | 1995-06-30 | Онкологический Институт Республики Молдова | Metodă de tratament a cancerului mamar |
| MD446G2 (ro) * | 1995-07-07 | 1996-11-30 | Онкологический Институт Республики Молдова | Metodă de tratament al cancerului mamar |
| MD798G2 (ro) * | 1996-11-15 | 1998-05-31 | Онкологический Институт Республики Молдова | Metoda de tratament a cancerului mamar |
| MD1569G2 (ro) * | 1999-12-17 | 2001-06-30 | Онкологический Институт Республики Молдова | Metodă de tratament al cancerului mamar în perioada preoperatorie |
-
2005
- 2005-05-16 MD MDA20050133A patent/MD2849G2/ro not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| MD2849G2 (ro) | 2006-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2018001677A1 (es) | Tratamiento de la enfermedad de fabry en pacientes no tratados y tratados previamente con ert | |
| RU2016102158A (ru) | Применение эрибулина и ленватиниба в качестве комбинированной терапии для лечения рака | |
| RU2014128513A (ru) | Раковый маркер и терапевтическая мишень | |
| BR112021022216A2 (pt) | Ácido 6-(2,4-diclorofenil)-5-[4-[(3s)-1-(3-fluoropropil)pirrolidin-3-il]oxifenil]-8,9-di-hidro-7h-benzo[7]anuleno-2-carboxílico para uso em pacientes com câncer de mama metastático ou avançado | |
| PH12020551715A1 (en) | Methods of treating cancer | |
| JP2019535816A5 (ro) | ||
| JOP20230106A1 (ar) | جسم مضاد ثنائي النوعية لـ tspan8/cd3 وجسم مضاد لـ tspan8 | |
| MD2849F1 (ro) | Metoda de tratament al cancerului mamar la pacientele de varsta inaintata | |
| Schmitt et al. | Extreme anemia (hemoglobin 1.8 g/dL) secondary to colon cancer | |
| MD3772F1 (ro) | Metoda de tratament al cancerului glandeimamare cu metastaze | |
| AR049135A1 (es) | Composicion,metodo, kit y tratamiento con oxaliplatino y un inhibidor del egfr,como erlotinib | |
| Laing et al. | Malignant melanoma in renal transplant recipients | |
| Czito et al. | A Phase I study of capecitabine, carboplatin, and paclitaxel with external beam radiation therapy for esophageal carcinoma | |
| RU2016143220A (ru) | Противоопухолевое средство, содержащее противоопухолевый комплекс платины, и усилитель противоопухолевого эффекта | |
| Mayer et al. | A Phase Ib Trial of Erlotinib, an EGFR Inhibitor, and Everolimus (RAD001), an mTOR Inhibitor, in Patients with Metastatic Breast Cancer. | |
| Redin et al. | Lurbinectedin synergizes with selinexor by inhibiting DNA damage repair and enhancing immune cell infiltration in neuroendocrine lung and prostate tumors | |
| Gay et al. | Cholecystokinin receptor antagonist proglumide reverses nonalcoholic steatohepatitis and prevents hepatocellular carcinoma | |
| Kubota et al. | Novel HER2-targeted gold nanoparticles; integration of antibody therapy and nanotechnology | |
| Gordeeva et al. | The efficacy of neoadjuvant chemotherapy and survival in older patients with stages II to III triple-negative breast cancer | |
| Chen | Targeting osteosarcoma with graphene oxide-associated anti-HER2 antibodies | |
| Mayer et al. | A phase I study of vandetanib and metronomic chemotherapy in advanced breast cancer. | |
| Taguchi | Capecitabine/phenytoin interaction | |
| PL1748770T3 (pl) | Leczenie i zapobieganie dobrotliwej chorobie sutka 4-hydroksytamoksyfenem | |
| WO2020076274A2 (en) | Development of unique caffeic acid phenethyl ester molecules that are candidates for being cancer drugs and determining biological activities thereof | |
| Kornreich | Epistaxis: case report |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| KA4A | Patent for invention lapsed due to non-payment of fees (with right of restoration) | ||
| MM4A | Patent for invention definitely lapsed due to non-payment of fees |